Can a drug stop kidney disease from coming back after transplant?
NCT ID NCT02683889
First seen Apr 18, 2026 · Last updated May 14, 2026 · Updated 5 times
Summary
This study tested the drug Acthar in 15 people with a kidney disease called FSGS who were getting a kidney transplant. The goal was to see if Acthar could lower the chance of FSGS coming back in the new kidney. Researchers measured how many patients had signs of FSGS in their transplant biopsies and urine tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FSGS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medstar Georgetown Transplant Institute
Washington D.C., District of Columbia, 20005, United States
Conditions
Explore the condition pages connected to this study.